T1	Treatment 10 23	empagliflozin
T2	Treatment 147 165	placebo-controlled
T3	Treatment 227 240	empagliflozin
T4	Treatment 447 474	randomized to empagliflozin
T5	Treatment 483 533	(n = 169), empagliflozin 25 mg (n = 155)
T6	Treatment 1230 1243	empagliflozin
T7	Treatment 1307 1320	empagliflozin
T8	Treatment 1336 1357	significantly reduced
T9	Treatment 1405 1418	p < 0.01)
T10	Treatment 1604 1634	Events consistent with urinary
T11	Treatment 1740 1762	events consistent with
T12	Treatment 1881 1897	insulin improved
